JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2005; 46:776-783, doi:10.1016/j.jacc.2004.11.073 (Published online 9 August 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rocha-Singh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rocha-Singh, K.

Evaluation of the Safety and Effectiveness of Renal Artery Stenting After Unsuccessful Balloon Angioplasty

The ASPIRE-2 Study

Krishna Rocha-Singh, MD*,*, Michael R. Jaff, DO{dagger}, Kenneth Rosenfield, MD{dagger} for the ASPIRE-2 Trial Investigators

* Prairie Heart Institute, Springfield, Illinois
{dagger} Massachusetts General Hospital, Boston, Massachusetts



View larger version (30K):

[in a new window]
  		Figure 1 Cumulative frequency distribution of percent diameter stenosis by quantitative angiographic analysis immediately before and after stent implantation. (All lesions treated with QA data available.) **In-stent measurements were used for post-procedure percent diameter stenosis. CI = confidence interval; COV = coefficient of variation; SD = standard deviation.

 


View larger version (27K):

[in a new window]
  		Figure 2 Probability of treatment benefit based on control of hypertension. Note: Peto formula was used for SE calculation (25). CI = confidence interval; SE = standard error of the mean.

 


View larger version (26K):

[in a new window]
  		Figure 3 Survival free from major adverse events (MAEs), to 720 days. All patients (n = 201). Note: Peto formula was used for SE calculation (25). CI = confidence interval; SE = standard error of the mean.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.